Wednesday - June 3, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to HealthPartners Neuroscience Center Research & Innovation
June 03, 2026
WASHINGTON, June 3 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to HealthPartners Neuroscience Center Research and Innovation from its Center for Drug Evaluation and Research:

* * *

Recipient: Leah R. Hanson, Ph.D., Senior Director, Neuroscience Research, HealthPartners Neuroscience Center Research and Innovation, 295 Phalen Boulevard, Saint Paul, MN 55130-2455, United States

Issuing Of . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products